Hjem › Ikke-småcellet lungekreft › Michigan › Farmington Hills
Kliniske studier for Ikke-småcellet lungekreft i Farmington Hills, MI
13 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Farmington Hills (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Corewell Health Farmington Hills Hospital, Farmington Hills
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi unna
- Henry Ford Medical Center-Columbus, Novi · 5 mi unna
- og 2 flere
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi unna
- Henry Ford Health Providence Southfield Hospital, Southfield · 8 mi unna
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RekruttererFase 1
- ALX Center 8, Farmington Hills
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RekruttererFase 2
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi unna
- Henry Ford Health Providence Southfield Hospital, Southfield · 8 mi unna
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekruttererFase 3
- Research Site, Farmington Hills
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Profound Research, LLC, Farmington Hills
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 3
- Profound Research, LLC, Farmington Hills
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruttererFase 3
- Weisberg Cancer Treatment Center, Farmington Hills
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
- Karmanos Cancer Institute, Farmington Hills
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RekruttererFase 2
- Oakland Medical Group, Farmington Hills
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Henry Ford Medical Center-Columbus, Novi · 5 mi unna
- Henry Ford West Bloomfield Hospital, West Bloomfield · 6 mi unna
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Henry Ford Medical Center-Columbus, Novi · 5 mi unna
- Henry Ford West Bloomfield Hospital, West Bloomfield · 6 mi unna
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
RekruttererFase 1/2
- Research Site, Farmington Hills
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Farmington Hills
- Parkinsons sykdom13 studier
- Fedme12 studier
- Overvekt10 studier
- Brystkreft10 studier
- Hjertesvikt9 studier
- Lungekreft8 studier
- Prostatakreft8 studier
- Alzheimers sykdom8 studier
- Blærekreft6 studier
- Multippel sklerose6 studier
- KOLS6 studier
- Lette kognitive vansker6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.